# Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

> **NCT01761526** · PHASE1 · COMPLETED · sponsor: **UCB BIOSCIENCES GmbH** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rotigotine transdermal patch

## Key facts

- **NCT ID:** NCT01761526
- **Lead sponsor:** UCB BIOSCIENCES GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2002-10
- **Final completion:** 2002-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761526, "Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01761526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*